Soluble CD163 was found to be a potential diagnostic parameter for monitoring the presence of macrophages, both in human biopsies of non-small cell lung cancer (NSCLC) (50) and human esophageal squamous cell carcinoma line (51). This evidence concerns the gene CD163 and non-small cell lung carcinoma.